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ABSTRACT 18 
 Type 1 interferons (IFNα/β) mediate immunologic host resistance to 19 
numerous viral infections including herpes simplex virus type 1 (HSV-1).  The 20 
pathways responsible for maintenance of IFNα/β signaling during the innate 21 
immune response to acute HSV-1 infection in the cornea are incompletely 22 
understood.  Using a murine ocular infection model, we hypothesized that the 23 
stimulator of IFN genes (STING) mediates host resistance to HSV-1 infection in 24 
the external ocular surface and preserves the structural integrity of this immune-25 
privileged mucosal site.  Viral pathogenesis, tissue pathology, and host immune 26 
responses during ocular HSV-1 infection were evaluated and characterized by 27 
plaque assay, esthesiometry, pachymetry, immunohistochemistry, flow 28 
cytometry, and siRNA transfection in wildtype C57BL/6 (WT), STING-deficient 29 
(STING-/-), and IFNα/β receptor-deficient (CD118-/-) mice at days 3-5 post 30 
infection (pi).  The presence of STING was critical for sustained control of HSV-1 31 
replication in the corneal epithelium and neuroinvasion, but loss of STING had a 32 
negligible impact with respect to gross tissue pathology.  Auxiliary STING-33 
independent IFNα/β signaling pathways were responsible for maintenance of the 34 
corneal integrity.  Lymphatic vessels, mast cells, and sensory innervation were 35 
compromised in CD118-/- mice concurrent with increased tissue edema.  STING-36 
dependent signaling led to the upregulation of tetherin, a viral restriction factor 37 
we identify to be important in containing the spread of HSV-1 in vivo.  38 
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INTRODUCTION 39 
 Viral infections set off cellular alarms through the detection of pathogen-40 
associated molecular patterns (PAMPs).  Virus-derived PAMPs are recognized 41 
by a variety of innate sensors that operate through distinct signaling pathways to 42 
upregulate IFNα/β and stimulate NF-κB-driven cytokine production.1 IFNα/β 43 
secretion mediates canonical autocrine and paracrine signaling through the 44 
IFNα/β receptor (CD118).  The IFNα/β signaling pathway modulates hundreds of 45 
IFN-stimulated genes (ISGs), the products of which activate immunologic 46 
countermeasures and promote host resistance to viral infections.2 Specific host-47 
pathogen interactions ultimately dictate the effectiveness of IFNα/β signaling, as 48 
many viruses including HSV-1 employ numerous mechanisms to evade, 49 
counteract, or otherwise disrupt pathway components or downstream ISGs.3,4 50 
 Multiple pattern recognition receptor families can initiate IFNα/β signaling 51 
during DNA virus infections.5–7 The pathways by which HSV-1-derived PAMPs 52 
mediate IFNα/β induction and host resistance within mucosal sites are 53 
incompletely understood.  Our lab has previously shown that loss of toll-like 54 
receptor (TLR) signaling does not enhance HSV-1 pathogenesis in the cornea; 55 
rather, a TLR-independent pathway involving the STING-dependent DNA sensor 56 
IFI16 (IFN inducible protein 16)  initiates host resistance to HSV-1 in the corneal 57 
epithelium.8 STING operates as a direct sensor of cytosolic DNA and a central 58 
signaling adaptor protein for an array of cytoplasmic and nuclear DNA sensors.6,9 59 
STING-dependent induction of IFNα/β involves activation of the transcription 60 
factor IFN regulatory factor 3 (IRF3) via phosphorylation by TANK-binding kinase 61 
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1 (TBK1).10 IFI16 has been linked to early IFNβ production in HSV-1-infected 62 
monocyte/macrophage cell lines, fibroblasts, and in the corneal epithelium.8,11,12 63 
However, IFI16 is degraded by the HSV-1 early gene product ICP0, suggesting 64 
that the STING-TBK1-IRF3 signaling axis is essential for early detection of viral 65 
infection but may be subsequently counteracted by the virus.11,13,14 We 66 
investigated the role of STING in sustained IFNα/β signaling in a mouse model of 67 
ocular HSV-1 infection, and hypothesized that STING mediates innate host 68 
resistance to corneal HSV-1 infection and preserves the corneal integrity through 69 
day 5 pi. 70 
 Currently, there are no prophylactic or therapeutic vaccines licensed to 71 
prevent sequelae elicited by HSV-1 infection.15 These medically relevant 72 
pathologies span in severity from intermittent mucocutaneous lesions (i.e. oral 73 
and genital herpes, herpetic keratitis) to neurological damage and corneal 74 
blindness.16 The cornea is a delicate mucosal site, and pathological alteration of 75 
the tissue architecture hinders visual acuity.  Recurrent corneal HSV-1 infection 76 
contributes to a variety of pathological sequelae in the human cornea that can 77 
affect visual acuity and health of the ocular surface including edema, scarring, 78 
neovascularization, and loss of sensation.15,17  79 
Our investigation highlights the subtleties of IFNα/β-signaling pathways in 80 
promoting resistance to ocular HSV-1 infection.  Resistance to HSV-1 involves 81 
the coordinated activities and interactions of many cell types and structures in the 82 
cornea to detect the viral infection, limit local replication, and impede spread to 83 
peripheral nerve ganglia.  Our findings collectively identify that the STING 84 
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signaling axis is critical for host resistance to corneal HSV-1 infection through a 85 
mechanism involving the viral restriction factor tetherin (also known as BST2, 86 
CD317, HM1.24, PDCA-1).  A wealth of evidence supports tetherin as a viral 87 
restriction factor active against a diverse range of enveloped viruses in vitro and 88 
in vivo by impeding cell-cell spread of nascent virions.18–20  We show that tetherin 89 
limits HSV-1 replication in the corneal epithelium and impedes viral dissemination 90 
to the nervous system.  91 
 92 
RESULTS  93 
STING promotes sustained resistance to HSV-1 replication in the eye  94 
 To identify the impact of STING relative to acute HSV-1 infection of the 95 
ocular surface, HSV-1 infection of the cornea was modeled using wild type (WT) 96 
C57BL6/J, STING-deficient (STING-/-), and highly susceptible IFNα/β receptor-97 
deficient (CD118-/-) mice.  By day 5 post infection (pi), STING-/- and CD118-/- mice 98 
harbored significantly more infectious virus in the cornea than WT mice (Figure 99 
1a).  A moderate increase in titer comparing CD118-/- mice to STING-/- mice was 100 
also observed (Figure 1a).  This data indicates that the STING-signaling pathway 101 
is a major determinant of IFNα/β-dependent host resistance within the cornea 102 
following HSV-1 infection. 103 
STING deficiency does not exacerbate acute corneal pathology  104 
 Corneal sensation and edema were measured following HSV-1 infection 105 
via Cochet-Bonnet esthesiometry and ultrasound pachymetry, respectively.  WT 106 
mice had no appreciable changes in corneal sensation (Figure 1b) relative to 107 
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healthy controls (not shown) by day 5 pi, though significant sensation loss and 108 
corneal denervation is observed in WT mice by day 8 pi using this experimental 109 
model.21 In contrast, CD118-/- mice exhibited hyperacute corneal sensation loss 110 
such that the pressure required to elicit a blink response was 15 g/mm2 higher 111 
than WT by day 5 pi (Figure 1b).   112 
 Despite the similar magnitude of infectious virus recovered from the 113 
corneas of STING-/- and CD118-/- mice, corneal sensation loss relative to WT was 114 
not observed in STING-/- mice through day 5 pi (Figure 1b).  Corneas of CD118-/- 115 
mice were more edematous than either STING-/- or WT mice by day 3 pi (Figure 116 
1c).  The severity of corneal edema continued to worsen in CD118-/- mice 117 
through day 5 pi, while differences in corneal thickness observed in WT and 118 
STING-/- mice following infection were generally unremarkable compared to 119 
baseline uninfected (UI) controls (Figure 1c).  Moreover, the mechanism 120 
underlying HSV-1 associated corneal sensation loss is likely dependent on 121 
intrinsic cell-signaling pathways and is not merely attributable to infection of the 122 
sensory neurons, as STING-/- and CD118-/- mice harbored 100-1000 times more 123 
infectious virus in the TG than WT by day 5 pi (data not shown; p ≤ 0.001). 124 
STING promotes host resistance in the corneal epithelium and restrains 125 
HSV-1 neuroinvasion 126 
 Confocal imaging was employed to visualize the localization of HSV-1 127 
antigen in cornea whole mounts at day 5 pi.  Viral lesions were geographically 128 
isolated in WT corneas, whereas diffuse HSV-1 labeling was observed in STING-129 
/- and CD118-/- corneas (Figure 1d).  High-magnification confocal analysis of the 130 
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viral lesions revealed that HSV-1 antigen is present almost exclusively in the 131 
outermost epithelial layers of WT and STING-/- corneas but penetrates into the 132 
deeper stromal layers of CD118-/- corneas (Figure 1e).     133 
 The pathogenesis of HSV-1 involves neuroinvasion and retrograde 134 
dissemination to the tissue-innervating trigeminal ganglion (TG) following 135 
infection of the oculo-orofacial mucosae.  Subbasal sensory nerve fibers of TG 136 
neurons innervate the corneal epithelium and enable direct epithelial-nerve 137 
spread of HSV-1.21  CD118-/- and STING-/- mice harbored 100 times more 138 
infectious HSV-1 in the TG than WT as early as day 3 pi (Supplemental Figure 139 
1a), indicating that STING-mediated signaling restricts dissemination of HSV-1 140 
from the corneal epithelium to the nervous system.  141 
STING deficiency leads to a minimal reduction in ISG expression 142 
 We hypothesized that the STING signaling axis drives and sustains 143 
IFNα/β production in the cornea following HSV-1 infection.  To investigate this 144 
hypothesis, a modest gene array was utilized to measure downstream ISGs at 145 
day 5 pi.  Cluster image mapping (Figure 2a) and quantification (Figure 2b) of 146 
compiled data show comparatively similar profiles for WT and STING-/- mice and 147 
a paucity of transcript expression in CD118-/- mice with respect to genes 148 
upregulated by IFNα/β-signaling.  Still, other genes are repressed by IFNα/β 149 
signaling22 such as Wars, which exhibits higher expression in the CD118-/- group 150 
than in WT or STING-/- samples (Figure 2b).  151 
 Statistical analysis divulged a reduction in transcript expression comparing 152 
STING-/- to WT mice for Bst2, Irf3, Irf9, Oas2, Oas3, and Rnasel (Figure 2b). Of 153 
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these, the viral restriction factor Bst2 (tetherin) was the only transcript identified 154 
with pronounced margins of differential expression.  Tetherin was highly 155 
upregulated in WT corneas yet expression was nearly 10 times lower in STING-/- 156 
and CD118-/- corneas (Figure 2b), consistent with the observed differences in 157 
viral pathogenesis in our model (Figure 1a).  Despite being statistically 158 
significant, expression differences in the other genes of interest were less 159 
impressive and not pursued.  160 
Amplified myeloid cell recruitment is observed in STING deficient mice  161 
 To uncover the immunologic mechanisms responsible for STING-162 
dependent resistance to HSV-1 in the cornea, infiltrating leukocytes and cytokine 163 
concentrations were investigated.  Flow cytometry was used to evaluate and 164 
characterize the cornea-infiltrating myeloid cells at day 5 pi.  STING-/- mice had 165 
nearly twice as many total infiltrating myeloid cells (CD45+ CD11b+) as WT mice 166 
(Figure 3a).  Confocal microscopy used to confirm uniform distribution of CD11b+ 167 
cells throughout cornea flat mounts at day 5 pi for all three genotypes (data not 168 
shown).  WT and CD118-/- mice had comparable total numbers of infiltrating 169 
myeloid cells (Figure 3a).  Ly6C and Ly6G antigens were used to distinguish 170 
monocytes and neutrophils (PMN).  No statistical difference was measured in the 171 
total number of cornea-infiltrating Ly6Clow Ly6Ghi PMN comparing WT, STING-/-, 172 
and CD118-/- mice, although there was a propensity for the proportion of PMN to 173 
be elevated in CD118-/- mice (Figure 3b).   174 
 Differences were observed in Ly6C+ cornea-infiltrating monocytes at day 5 175 
pi.  We identified two distinct Ly6C+ (mid-high) monocyte populations comprising 176 
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Ly6Ghigh (Figure 3c) and Ly6Glow (Figure 3d) subsets.  The ratio of the Ly6Ghigh to 177 
Ly6Glow monocyte subsets was also evaluated (Figure 3e).  The Ly6C+ Ly6Glow 178 
monocyte population is largely absent in the corneas of CD118-/- mice (Figure 3d) 179 
consistent with their identity as inflammatory monocytes, which serve as innate 180 
sentinels against HSV-1.23 Representative dot plots are shown for WT, STING, 181 
and CD118-/- mice (Figure 3f).  A higher ratio of Ly6C+ Ly6Ghigh monocytes was 182 
observed in the CD118-/- corneas compared to STING-/- or WT groups (Figure 183 
3e), and a higher total number of Ly6C+ Ly6Ghigh monocytes were present in the 184 
corneas of STING-/- mice than in other groups.  185 
 Despite the high number of inflammatory monocytes (Ly6C+ Ly6Glow) 186 
recruited into the corneas of STING-/- mice, HSV-1 replication in the epithelium is 187 
not controlled (Figure 1a,e).  However, gross tissue edema (Figure 1c) and viral 188 
penetration into the stroma (Figure 1e) are prevented in STING-/- mice, which we 189 
attribute in part to the antiviral effects of inflammatory monocyte infiltration. 190 
Protein concentrations of IFNα2,4  and IFNγ in STING-/- corneas were comparable 191 
to or exceeded WT at day 5 pi (Figure 3g), thus substantiating the ISG array 192 
findings (Figure 2).  No elevation in IFNα2,4  concentrations were observed in WT 193 
or STING-/- corneas relative to UI at day 3 pi (not shown). Concentrations of the 194 
monocyte chemotactic C-C motif chemokine ligands CCL2 and CCL20 were 195 
elevated in STING-/- corneas at day 5 pi (Figure 3h), thus providing a mechanistic 196 
explanation for the observed enhancement in monocyte infiltration.23,24 197 
Production of the proinflammatory cytokines IL-1β and IL-17 were also measured 198 
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(Figure 3i), but the concentrations detected did not correlate with severity of 199 
tissue pathology or viral pathogenesis.  200 
 In order to rule out a potential functional defect in the inflammatory 201 
monocytes in STING-/- mice, CD11b+ splenocytes were isolated from uninfected 202 
WT or STING-/- mice and inoculated in vitro with HSV-1 at various multiplicities of 203 
infection (MOI).  Supernatant virus titers did not differ between WT and STING-/-  204 
CD11b+ splenocyte cultures observed at 24 hours pi (Supplemental Figure 2a).  205 
By 48 hours pi, similar findings were observed in culture supernatants with a 206 
subtle variance at 1 MOI in which there was a modest but statistically significant 207 
increase in HSV-1 recovered from the infected CD11b+ STING-/- cell cultures 208 
(Figure 3j).   209 
Prior to isolation of CD11b+ cells, splenocytes isolated from healthy WT 210 
and STING-/- mice had a similar distribution of CD45+ CD11b+ myeloid cell 211 
subsets based on Ly6C and F4/80 antigen expression (Supplemental Figure 2b).  212 
CD11b+ splenocytes cultured for 24 hours showed no differences in the relative 213 
proportions of F4/80+ Ly6C– macrophages or F4/80+ Ly6Cmid-high monocytes in the 214 
presence or absence of HSV-1 (Supplemental Figure 2c,d).  Consistent with 215 
previous findings,25 macrophages isolated from STING-/- mice exhibited a deficit 216 
in major histocompatibility class II (MHC II) upregulation relative to WT in HSV-1 217 
infected cultures (Supplemental Figure 2d).  However, MHC II expression profiles 218 
were similar in both WT and STING-/- monocyte subsets (Supplemental Figure 219 
2c,d), thereby providing no phenotypic indication of functional defects in STING-/- 220 
monocytes. 221 
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Peri-corneal lymphatic vessels and mast cells are lost in CD118-/- mice  222 
  Corneal neovascularization and/or impairment of the peri-corneal 223 
vasculature were examined to further characterize differences in acute ocular 224 
pathology following HSV-1 infection.  Blood and lymphatic vessels were labeled 225 
using anti-CD31 and anti-Lyve-1 antibodies, respectively, to visualize the peri-226 
corneal vasculature at day 5 pi (Figure 4a).  The vasculature of STING-/- mice 227 
resembled WT (Figure 4a).  Neovascularization was modest in the WT and 228 
STING-/- mice and notably absent in the CD118-/- animals by day 5 pi (Figure 4a) 229 
relative to healthy UI corneas (not shown).  The peri-corneal blood vessels 230 
remaining in CD118-/- mice were distended relative to those seen in STING-/- or 231 
WT mice (Figure 4a) consistent with observations of enhanced tissue edema in 232 
CD118-/- mice (Figure 1c).  Moreover, a profound loss of the lymphatic 233 
vasculature is observed in CD118-/- mice by day 5 pi (Figure 4a).26  234 
 Tissue-resident mast cells associated with the peri-corneal vasculature 235 
were also investigated at day 5 pi due to their pleiotropic immunomodulatory 236 
capacity27 and protective role against ocular HSV-1 infection.28 Mast cells were 237 
identified by avidin staining and found in the limbal aspect of the corneas of WT 238 
and STING-/- mice as previously described.28 In stark contrast, mast cells were 239 
lost in the corneas of CD118-/- mice by day 5 pi (Figure 4b).  We speculate the 240 
pathological corneal edema observed in CD118-/- mice results from multiple 241 
mechanisms including: penetration of HSV-1 into the stroma, lymphatic vessel 242 
destruction, and loss of mast cells.  243 
STING is required for tetherin expression in the corneal epithelium 244 
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  A direct STING-dependent mechanism responsible for containment of viral 245 
replication and dissemination remained to be identified.  Due to its expression 246 
profile in the ISG array, the viral restriction factor tetherin was explored as a 247 
candidate in controlling HSV-1 in the corneal epithelium.  We hypothesized that 248 
tetherin impedes spread of HSV-1 in the cornea in a STING-dependent manner.  249 
Immunolabeling in WT, STING-/-, and CD118-/- corneas at day 5 pi was utilized to 250 
identify the presence and localization of tetherin (Figure 4c).  Tetherin colocalized 251 
with the CD31+ blood vessels in all groups.  In contrast, high levels of tetherin 252 
protein expression was observed in the corneal epithelium of WT but not STING-/- 253 
or CD118 mice-/- (Figure 4c).  Tetherin expression was not observed in 254 
uninfected corneal epithelium (not shown).  Supplemental Movie 1 highlights the 255 
differential expression of tetherin in the epithelium by 3-dimensional confocal 256 
reconstructions of WT and STING-/- corneas.  Punctate tetherin labeling in the 257 
deeper stromal layers of the corneas show infiltrating leukocytes which also 258 
express tetherin (Supplemental Movie 1).29  259 
 Tetherin expression was also evaluated in the TG by PCR at day 5 pi 260 
(Supplemental Figure 1b) in light of evidence showing tetherin expression in 261 
neurons30,31 and the enhanced trafficking of HSV-1 from the cornea to the TG in 262 
STING-/- and CD118-/- mice observed herein (Supplemental Figure 1a).  Though 263 
STING is required for tetherin expression in the corneal epithelium (Figure 4c, 264 
Supplemental Movie 1), tetherin is upregulated in the TG of STING-/- mice 265 
similarly to WT at an approximate 8-fold increase over UI yet conspicuously 266 
absent in CD118-/- TG at day 5 pi (Supplemental Figure 1b).  The differential 267 
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induction of tetherin exemplifies the specificities and complexities of IFNα/β-268 
mediated ISG stimulation in various tissues.  Furthermore, it emphasizes that 269 
different anti-viral mechanisms control HSV-1 replication in different constituent 270 
cell types.   271 
Tetherin impedes local HSV-1 spread and neuroinvasion 272 
 Lack of tetherin expression in the corneal epithelium of STING-/- and 273 
CD118-/- mice correlated with the observed increases in HSV-1 titers and 274 
unencumbered expression of HSV-1 antigen throughout the epithelium compared 275 
to WT animals.  However, definitive evidence substantiating the role of tetherin in 276 
impeding local viral replication and neuroinvasion remained to be shown.  siRNA 277 
transfection was used to limit tetherin expression in the corneas of WT mice 278 
pursuant to HSV-1 infection independent of ancillary IFNα/β-signaling 279 
deficiencies.  Knockdown efficiency (Figure 5a) was greater than 70% at 48 280 
hours pi at the transcript level, and trends in expression differences persisted at 281 
72 hours pi.  However, transcript expression differences were not statistically 282 
significant by the latter time point, therein demonstrating the transient nature of 283 
siRNA-mediated knockdown.  Knockdown was validated at the protein level 284 
using confocal imaging to analyze the fluorescence intensity of tetherin 285 
immunolabeling in scramble and tetherin-specific siRNA-treated corneas at 72 286 
hours pi (Figure 5b,c).  Isotype control antibody labeling was used to validate the 287 
specificity of tetherin immunolabeling (Figure 5b). 288 
 Viral burden in the corneas and TG (Figure 5d) of siRNA-treated mice was 289 
subsequently measured.  Local tetherin knockdown in the corneal epithelium led 290 
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to a significant increase in HSV-1 titer in the cornea and TG compared to 291 
scramble siRNA transfected controls at day 3 pi (Figure 5d).  Consistent with the 292 
temporary effect of tetherin knockdown, no differences in viral titer were 293 
observed by day 5 pi in the cornea or TG (not shown) comparing the two siRNA-294 
treated groups.  Collectively, our data show that tetherin is indeed a functional 295 
viral restriction factor for HSV-1 in vivo.  Specifically, we show that tetherin 296 
expression in the corneal epithelium is STING-dependent.  Furthermore, we 297 
demonstrate that tetherin sequesters HSV-1 in the microenvironment of the 298 
corneal epithelium in order to inhibit local cell-cell spread, impede invasion of 299 
sensory nerve fibers, and consequentially restrict viral dissemination to the 300 
nervous system.   301 
 302 
DISCUSSION 303 
 Early IFNα/β induction through pathogen recognition receptor signaling is 304 
critical for the control of HSV-1 infection.  Our previously reported data show that 305 
corneal viral titers in MyD88- or TRIF-deficient mice are no different than WT by 306 
day 5 pi;8 however, the corneal HSV-1 titer at day 5 pi in STING-/- mice was more 307 
consistent with the highly susceptible CD118-/- mice in the present study.  308 
Collectively, our data demonstrate that a TLR-independent, STING-dependent 309 
process mediates initial and sustained resistance to acute HSV-1 infection in the 310 
cornea prior to the induction of an adaptive immune response.  311 
 The basic resident cell composition of the murine cornea includes 312 
epithelial cells, stromal keratocytes, and endothelial cell layers in addition to 313 
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tissue-resident leukocytes, sensory nerve fibers and peripheral vasculature.  314 
Each of these cell types and structures likely provide distinct contributions to 315 
defense against HSV-1 infection that collectively combat viral replication and 316 
spread.  Likewise, corneal HSV-1 infection may directly or indirectly elicit unique 317 
pathologies affecting each of these components.  Blood and lymphatic vessels 318 
surrounding the cornea play unique roles during infection by facilitating leukocyte 319 
influx and efflux of extracellular fluid and macromolecules, respectively. 320 
 Stark differences were observed with respect to corneal pathology 321 
comparing STING-/- to CD118-/- mice despite a similar viral burden.  The severe 322 
corneal edema exhibited by CD118-/- mice correlated with a hyperacute sensory 323 
deficit following HSV-1 infection.  These findings support established notions that 324 
inflammatory processes in the cornea induce loss of innervation, and that local 325 
trophic factors maintain or restore the delicate corneal sensory fibers following 326 
injury or pathogenic insult.21,32,33 The present investigation expands the 327 
mechanistic understanding of corneal denervation following HSV-1 infection by 328 
identifying sensation loss transpires independent of the viral burden locally in the 329 
cornea or in the TG. 330 
 Corneal HSV-1 infection with high-titer inoculums can elicit inflammatory 331 
neovascularization during the acute stage of infection.34 Moreover, lymphatic 332 
vessels are infected and destroyed by HSV-1 absence of IFNα/β signaling.26 333 
Observations from the present investigation suggest that while STING is critical 334 
for containment of HSV-1 replication and spread in the corneal epithelium, an 335 
auxiliary STING-independent yet IFNα/β-dependent pathway protects the corneal 336 
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stroma and peripheral lymphatic vessels from HSV-1 infection and resultant 337 
edema.   338 
 The selective loss of mast cells in CD118-/- but not in STING-/- mice again 339 
supports the importance of STING-independent IFNα/β-signaling pathways in the 340 
maintenance of the corneal architecture.  Mast cells likely provide support for 341 
peri-corneal lymphatic vessels and may also contribute to inflammatory 342 
lymphangiogenesis in the cornea as has been shown in other sites.35–37 Our 343 
findings collectively emphasize the importance of IFNα/β-signaling not only with 344 
respect to its anti-viral properties, but highlight its role in maintaining tissue 345 
integrity and preservation of visual acuity.   346 
 Multiple studies have established that IFNα/β signaling in both resident 347 
and bone marrow-derived cells is critical for resistance to acute HSV-1 infection 348 
in the cornea.23,26 We observed a profound increase in the myeloid cell infiltrate 349 
in corneas of STING-/- mice relative to WT consistent with a recent report 350 
describing the role of STING-dependent suppression of excessive immune 351 
activation.38 Our lab has previously shown that of the infiltrating myeloid-lineage 352 
leukocytes, inflammatory monocytes (CD45+ Gr-1+ F4/80+) facilitate virus 353 
clearance and are recruited by CCL2 following acute HSV-1 infection in the 354 
cornea.23  355 
 We have now identified two distinct monocyte populations in the cornea at 356 
day 5 pi.  Of these, the Ly6C+ Ly6Glow population reflects protective inflammatory 357 
monocytes.  The secondary Ly6C+ Ly6Ghigh monocyte population observed in the 358 
cornea has been described in hypoxic metastatic niches39–41 and during 359 
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pulmonary viral infection concomitant with a lack of IFNα/β signaling and altered 360 
chemokine production.42 The concept of distinct monocyte subsets with notable 361 
plasticity, phenotypic variation, and functional diversity is now well established for 362 
a wide variety of pathologies.43–47  363 
 Inflammatory monocytes are efficiently recruited to the corneas of STING-/- 364 
mice and prevent excessive tissue pathology beyond the surface barrier 365 
epithelium. In vitro data indicate that human macrophages and murine myeloid 366 
dendritic cells utilize a STING-dependent pathway for recognition of HSV-1 and 367 
subsequent induction of IFNβ, cytokine production, and autophagy.48–50 368 
Accordingly, we investigated MHC II upregulation as an indicator of monocyte 369 
activation in the absence of STING, and found no defect compared to WT 370 
monocytes in vitro, though a defect in MHC II upregulation was observed in 371 
STING-/- macrophages (Supplemental Figure 2c,d).  372 
 Anti-viral restriction factors serve as wardens for controlling viral infections 373 
by arresting virus replication and spread.  Tetherin is a type II transmembrane 374 
protein that shares topographical homology with several prion proteins which 375 
express multiple membrane anchors, including a glycosyl-phosphatidylinositol 376 
(GPI) anchor.20 Tetherin is upregulated by IFN signaling (IFN-α/β, -γ, and -λ) and 377 
is inducible in polarized epithelial cells, constitutively expressed by blood vessel 378 
endothelial cells and many leukocytes.18,29,51 Tetherin promotes endocytosis and 379 
degradation of enveloped virions bound to the cell surface, and is implicated in 380 
transcription of NFκB-regulated cytokines.52   381 
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 Following successful replication of HSV-1 in epithelial cell nuclei, nascent 382 
HSV-1 virions must egress through the nuclear membrane, trans-Golgi network, 383 
and plasma membrane to infect neighboring cells.53 The GPI anchor of tetherin 384 
facilitates attachment to and retention of enveloped viruses upon virion budding 385 
from the trans-Golgi network and plasma membranes to reduce cell-cell 386 
spread.54 Furthermore, reports indicate that HSV-1 employs at least two distinct 387 
mechanisms to counteract tetherin and evade restriction in vitro.55,56 However, 388 
the in vivo relevance of tetherin with respect to HSV-1 infection has not been 389 
reported.  Our in vivo data show that tetherin sequesters HSV-1 replication and 390 
spread in the cornea in addition to restricting neuroinvasion and dissemination of 391 
the virus to peripheral nerve ganglia.  Furthermore, our findings detail a novel 392 
mechanism of HSV-1 restriction involving a STING-dependent, IFNα/β-mediated 393 
signaling pathway that induces tetherin expression in epithelial cells within the 394 
ocular mucosae.395 
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METHODS 396 
Mice and virus.  C57BL/6J WT and STING-/- mice were obtained from the 397 
Jackson Laboratory.  CD118-/- and STING-/- mice were bred in-house.  All mice 398 
were maintained in a specific pathogen-free vivarium at the Dean McGee Eye 399 
Institute (University of Oklahoma Health Sciences Center, Oklahoma City, OK). 400 
Mice were euthanized by cardiac perfusion with 10-15 ml of 1x PBS.  All 401 
experimental procedures were conducted in accordance with protocols approved 402 
by Institutional Animal Care and Use Committees.  HSV-1 strain McKrae was 403 
used for all experiments; the stock concentration was 7.07x107 plaque forming 404 
units (pfu) per ml. 405 
Infection and plaque assays.  Six to twelve week old mice were anesthetized 406 
by ketamine (100 mg/kg) and xylazine (6.6 mg/kg) injection ip. Following partial 407 
epithelial debridement of the cornea using a 25-gauge needle, an inoculum of 408 
1000 pfu of HSV-1 was applied to each eye.  Tissues collected from euthanized 409 
animals for standard plaque assays were homogenized and supernatants titered 410 
on confluent CCL-81 Vero cell (ATCC, Manassas, VA) monolayers in microtiter 411 
plates as described previously.28  412 
Corneal pathology.  Ultrasound pachymetry was utilized to monitor corneal 413 
thickness and edema following infection using a Corneo-Gage Plus digital 414 
pachymeter (Sonogage, Cleveland OH) as described previously.28 Corneal 415 
sensation or blink reflex sensitivity was evaluated using a handheld Cochet-416 
Bonnet esthesiometer as described previously.21 Cochet-Bonnet filament length-417 
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scores were interpolated into threshold sensitivity pressures using conversions 418 
provided by the manufacturer.  419 
Gene array. Transcript expression studies on corneas were performed using 420 
PrimePCR pathway analysis technology from Bio-Rad (Hercules, CA) for 421 
selected genes according to the manufacturer’s directions.  RNA was isolated 422 
from corneas and converted into cDNA as described previously.8 Relative gene 423 
expression was calculated by the standard 2-ΔΔCt method using GAPDH and TBP 424 
as reference genes following semi-quantitative real time PCR using a CFX 425 
Connect thermocycler and PrimePCR technology (Bio-Rad).  Transcripts 426 
evaluated are listed in Figure 2.  Gene expression profiles represented by the 427 
cluster image map in Figure 2 were generated using the National Cancer 428 
Institute’s CIMminer tool freely accessible online. 429 
Flow cytometry. Corneas were harvested from enucleated eyes of euthanized 430 
animals and digested in 2 mg/ml type 1 collagenase from Clostridium 431 
histolyticum (Sigma-Aldrich, St. Louis, MO) in RPMI 1640 media supplemented 432 
with 10% FBS, gentamicin, and antibiotic/antimycotic cocktail (Invitrogen, Grand 433 
Island, NY) for 2-2.5 hours at 37°C with gentle mechanical trituration every 15 434 
minutes.  The suspension was subsequently filtered through 40μm mesh, 435 
washed with 1% BSA in 1x PBS (wash buffer), pelleted, and labeled for flow 436 
cytometric analysis. Cells were immunolabeled for 30 minutes at 4°C following a 437 
15 minute incubation with anti-CD16/32 Fc block.  Antibodies were obtained from 438 
AbD Serotec (Raleigh, NC), eBioscience (San Diego, CA), BD Biosciences (San 439 
Jose, CA) to label CD11b, CD45, F4/80, I-A/I-E, Ly6C, and Ly6G leukocyte 440 
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antigens.  Following labeling, cells were washed twice, fixed in 1% PFA (Sigma-441 
Aldrich) and stored overnight at 4°C.  Samples were pelleted and resuspended in 442 
1 ml wash buffer for analysis on a MacsQuant flow cytometer (Miltenyi Biotech, 443 
Bergisch Gladbach, Germany).  444 
Immunoassays. Corneas harvested at the indicated times pi and homogenized 445 
in 1x PBS containing 1x protease inhibitor set 1 (EMD Millipore, Billerica, MA). 446 
Supernatants were used at the indicated times pi to evaluate protein 447 
concentrations of IFNα by ELISA (eBioscience) or CCL2, CCL20, IFNγ, IL-1β, 448 
and IL-17 by Bio-Plex (Biorad) suspension array according to the manufacturers’ 449 
directions.  450 
Splenocyte isolation and cultures. Spleens were harvested from euthanized 451 
mice, teased into single cell suspensions, and depleted of erythrocytes as 452 
described previously.28 Immunomagnetic beads (Miltenyi Biotech) were used to 453 
isolate CD11b+ splenocytes by positive selection according to the manufacturer’s 454 
instructions.  Cultures of 1x105 cells were incubated at 37˚C for 24-48 hours at 455 
5% CO2 in 1 ml RPMI 1640 media supplemented with 10% FBS, gentamicin, and 456 
antibiotic/antimycotic cocktail (Invitrogen).  Supernatants were collected for 457 
plaque assay and cells were labeled for analysis by flow cytometry.  458 
Microscopy.  For confocal microscopic analysis of vasculature, mast cells, and 459 
tetherin expression, corneolimbal buttons were harvested from enucleated eyes 460 
of euthanized animals, fixed in 4% PFA for 30 minutes at 4°C, washed 3 times 461 
for 15 minutes in 1% Triton X-100 (Sigma-Aldrich) in 1x PBS, and 462 
immunolabeled or stained.  Samples were washed between primary and 463 
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secondary antibodies.  Antibodies used to label cornea whole mounts were 464 
obtained from Abcam (Cambridge, MA), eBioscience, Dako (Carpinteria, CA), 465 
EMD Millipore, or Jackson ImmunoResearch (WestGrove, PA).  FITC-conjugated 466 
avidin was used to stain peri-corneal mast cells (Biolegend, San Diego, CA) as 467 
shown previously.28 Flat mounts of the tissue were prepared and imaged using 468 
an Olympus FV500 confocal microscope (Center Valley, PA).  Olympus Fluoview 469 
and iMovie (Apple, Cupertino, CA) software were used to generate 3D Z-stack 470 
renderings and video highlighting the topographical localization of tetherin 471 
expression in the cornea (Supplemental Movie 1).  472 
In vivo transfection. Ambion Silencer Select siRNA (Invitrogen) was used for 473 
corneal knockdown experiments and transfection mediated using lipofectamine 474 
2000 (Invitrogen) as described previously.8 Briefly, partial epithelial debridement 475 
of corneas of anesthetized WT mice was conducted to prepare the eye for 476 
transfection.  Next, 3.33 μmol tetherin-specific or nonspecific scramble control 477 
siRNA in supplement-free DMEM media was applied to each cornea in a 10 μl 478 
eye drop containing 5 μl Lipofecamine 2000 (Invitrogen). siRNA sequences were 479 
designed and validated by the manufacturer.  Mice were infected with HSV-1 16 480 
hours post-transfection.  On days 2, 3, or 5 pi, corneas were harvested for plaque 481 
assay and validation of knockdown efficiency.  Tetherin transcript expression was 482 
quantified using PrimePCR technology (Biorad) as described for the gene array. 483 
Tetherin protein was imaged in immunolabeled cornea flat mounts by confocal 484 
microscopy. 485 
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Statistical analysis.  Normal distribution of all data was assumed a priori.  486 
Graphical representations of data reflect mean ± SEM.  Statistical analysis of all 487 
data was performed using GraphPad Prism 5 (La Jolla, CA).  One-and two-way 488 
ANOVAs were used to distinguish differences among data sets while  489 
significance thresholds for sample means were identified using Student-490 
Newman-Keuls multiple comparison tests or Bonferroni posttests, respectively.  491 
A standard unpaired Student’s T test was used when applicable.  492 
Online supplemental material. Supplementary data is available online at 493 
www.nature.com/mi  494 
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FIGURE LEGENDS 655 
Figure 1: Viral burden and acute pathology in the cornea. (a) Viral titers at 656 
day 5 pi in fellow corneas of WT, STING-/-, and CD118-/- mice (n = 7-8 657 
mice/group, 3 independent experiments). (b) Corneal sensitivity measured using 658 
a Cochet-Bonnet esthesiometer on day 5 pi. Black bars reflect Cochet-Bonnet 659 
score/ filament length in cm (left axis); red open circles reflect corneal sensation 660 
threshold in g/mm2 (right axis), i.e. minimum pressure required to elicit a blink 661 
response (n = 16 corneas/group, 3 independent experiments). (c) Ultrasound 662 
pachymetry measurements of corneal thickness in uninfected and infected mice 663 
through day 5 pi (n = 14-20 corneas/group/time point; 4 independent 664 
experiments). For panel c, * indicates differences between WT and STING-/- or 665 
CD118-/-; ^ indicates differences between STING-/- and CD118-/- mice; 666 
significance threshold: *p < 0.05, **p < 0.01, ***p < 0.001. (d) Representative 10x 667 
confocal images illustrating localization of viral antigen in cornea whole mounts at 668 
day 5 pi; scale bar = 100 μm. (e) 60x images of viral lesions from (d) with 60 μm 669 
z-stack focal projections illustrating HSV-1 labeling in the epithelium and 670 
penetration into the stroma; scale bar = 20 μm.  671 
 672 
Figure 2: IFNα/β regulated gene expression. (a) Cluster image map summary 673 
of selected IFNα/β-regulated transcript expression relative to the geometric mean 674 
of GAPDH and TBP expression at day 5 pi (standardized to UI WT corneas using 675 
the 2-ΔΔCT method).  (b) Quantified expression values for selected genes (n = 6-8 676 
mice/group; 3 independent experiments). For panel b, * indicates differences 677 
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between WT and STING-/- or CD118-/-; ^ indicates differences between STING-/- 678 
and CD118-/- mice; *p < 0.05, **p < 0.01, ***p < 0.001. Bst2 (Bone marrow 679 
stromal antigen 2; tetherin), Ch25h (cholesterol 25 hydroxylase), Eif2ak2 680 
(eukaryotic initiation factor 2α kinase 2), Ifnb (IFNβ), Irf (IFN regulatory factor), 681 
Nos2 (inducible nitric oxide synthase), Oas (oligoadenylate synthetase), Rnasel 682 
(2’-5’ Oas-dependent ribonuclease), Wars (tryptophan aminoacyl-tRNA 683 
synthetase).  684 
 685 
Figure 3: Leukocyte recruitment and function.  Total cornea-infiltrating CD45+ 686 
CD11b+ myeloid-lineage leukocytes (a), Ly6Clow Ly6Ghi PMN (b), Ly6C+ Ly6Ghigh 687 
monocytes (c), Ly6C+ Ly6Glow monocytes (d) at day 5 pi (n = 8 mice/group; 3 688 
independent experiments). (e) Ratio of cornea-infiltrating Ly6Ghigh:Ly6Glow Ly6C+ 689 
monocytes. (f) Representative flow plots of cornea-infiltrating CD45+ CD11b+ 690 
myeloid-lineage leukocyte subsets in WT, STING-/- and CD118-/- mice are 691 
featured in the following gates: Ly6C+ Ly6Glow monocytes (top central), Ly6C+ 692 
Ly6Ghi monocytes (top right), Ly6Clow Ly6Ghi PMN (lower right).  Protein 693 
concentrations of IFNα2,4 and IFNγ (g); monocyte-chemotactic cytokines CCL2 694 
(c-c motif chemokine ligand 2) and CCL20 (h); and inflammatory mediators IL-1β 695 
and IL-17 (i) in cornea pairs at day 5 pi (n = 10-17 mice/group infected, 1-3 UI 696 
controls; 2-3 independent experiments). For panels (g - i), * indicates differences 697 
between WT and STING-/- or CD118-/-; ^ indicates differences between STING-/- 698 
and CD118-/- mice.  (j) Viral titers from supernatants of CD11b-enriched 699 
splenocytes cultured in vitro with HSV-1 for 48 hours at various multiplicities of 700 
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infection (MOI) (n = 3-6 culture samples per group; 2 independent experiments). 701 
Significance thresholds: *p < 0.05, **p < 0.01, ***p < 0.001 comparing the 702 
indicated groups. 703 
 704 
Figure 4: Vasculature, mast cells, and tetherin expression at day 5 pi. 705 
Representative 10x immunofluorescent confocal images of cornea flat mounts 706 
prepared at day 5 pi from 3-5 mice/group are shown.  Lymphatic and blood 707 
vessels were labeled using Lyve-1 and CD31-specific antibodies, respectively 708 
(a). Mast cells stained with FITC-avidin reside along the limbal margin 709 
demarcated by Lyve-1 positive lymphatic vessels (b). Tetherin immunolabeling 710 
(c) highlights the constitutive tetherin expression on blood but not lymphatic 711 
vessels, and IFN-inducible expression in the epithelium (images in panels a and 712 
c are of the same sample). White dotted lines demarcate the separation between 713 
the cornea and limbus. Scale bars = 100 μm. 714 
 715 
Figure 5: Tetherin restricts local HSV-1 spread and neuroinvasion in vivo. 716 
Corneas of WT mice were transfected with scramble or tetherin-specific siRNA, 717 
infected, animals euthanized at day 3 or 5 pi, corneas and TG harvested for 718 
PCR, 40x confocal imaging, or plaque assay on corneas and TG. (a) 719 
Quantification of tetherin expression relative to GAPDH and TBP expression in 720 
transfected corneas at 48 and 72 hours pi (n = 5 animals/group/end point; 2 721 
independent experiments; * = p value ≤ 0.05). (b) Representative images of 722 
isotype or tetherin-specific antibody labeling with DAPI stain for contrast in the 723 
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corneal epithelial layers of target or scramble siRNA transfected corneas at day 3 724 
pi (scale bar = 20 μm). (c) Relative siRNA-mediated tetherin protein knockdown 725 
shown as images and isometric histogram projections of tetherin MFI from panel 726 
b.  Imaging was conducted on 3-4 corneas/group; 2-3 independent experiments.  727 
(d) HSV-1 titers in individual scramble control and tetherin-specific siRNA 728 
transfected mouse corneas (representative data from 1 of 2 experiments shown; 729 
n = 6-7 corneas/group total) and TG (n = 8-9 TG/group; 3 independent 730 
experiments); * = p < 0.05 comparing scramble siRNA to tetherin siRNA 731 
transfected groups.732 
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DESCRIPTIONS FOR SUPPLEMENTAL MATERIAL 733 
 734 
Supplemental Figure 1. (a) HSV-1 titers at day 3 pi (n = 6 TG per group; 2 735 
independent experiments) . (b) Relative expression of tetherin in the TG at day 5 736 
pi (n = 8-12 TG/group; 3 independent experiments). For panels (a,b), * indicates 737 
differences between WT and STING-/- or CD118-/-; ^ indicates differences 738 
between STING-/- and CD118-/- mice. Significance thresholds: *p < 0.05, ***p < 739 
0.001 comparing the indicated groups. 740 
 741 
 742 
Supplemental Figure 2. (a) HSV-1 titers in splenocyte culture supernatants at 743 
24 hours pi (b) Representative flow plots of splenocytes freshly isolated from UI 744 
WT or STING-/- mice pregated on CD45+ CD11b+ to show equal heterogeneity of 745 
the myeloid cell subsets based on Ly6C and F4/80 antigen expression. (c) 746 
Representative flow plots for uninfected CD11b+ splenocyte cultures pregated on 747 
CD45+ cells at 24 hours pi.  Macrophages (F4/80+ Ly6C–) are gated in black 748 
boxes and monocyes (Ly6Cmid/high F4/80high/mid) in blue and pink ovals, 749 
respectively.  Histograms show MHC II expression from each gated population. 750 
(d) Cultured CD11b+ splenocytes inoculated at MOI = 10 and analyzed as in (c).   751 
(d) Isotype antibody labeling of MHC II in WT HSV-1 inoculated (MOI = 10) 752 
CD11b+ cultures at 24 hours pi.  All experiments: n = 3-6 culture samples per 753 
group; 2 independent experiments. 754 
  755 
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Supplemental Movie 1. Localization of tetherin expression in a 3-dimensional 756 
reconstruction of a confocal full-thickness Z-stack image of WT and STING-/- 757 
corneas captured at 60x magnification on day 3 pi. A honeycomb-like patterning 758 
is observed in the corneal epithelium, but labeling is punctate in the deeper 759 
stromal layer consistent with tetherin expression on infiltrating leukocytes.  760 







